about
Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.Neuromuscular issues in systemic disease.Overcoming challenges in the diagnosis and treatment of myasthenia gravis.Treatment of muscle weakness in neuromuscular disorders.Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis.Myasthenia gravis with antibodies to MuSK: an update.Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.
P2860
Q38306801-A038197A-EE71-433E-A663-CF1321AE7762Q38501865-58AB45A8-DB22-46D6-BD31-76CFD7A92585Q38671442-820A66AA-C681-4CEB-B9F9-47199E3BEBC8Q38845507-85299355-56B2-4B9D-9A6B-2FA09BF10F3FQ38899380-2FD5B3F5-519D-4016-8C77-C1E3AA0BEEB1Q47674286-5ECEFAE5-6B39-4BC3-A323-24EFCDE61F83Q54116089-8C58A0A3-BBCE-4CD2-84D4-E95B092487CFQ55267717-D0B8CCB2-EA7C-460D-A452-487384F8EB00
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Treatment of MuSK-Associated Myasthenia Gravis.
@en
Treatment of MuSK-Associated Myasthenia Gravis.
@nl
type
label
Treatment of MuSK-Associated Myasthenia Gravis.
@en
Treatment of MuSK-Associated Myasthenia Gravis.
@nl
prefLabel
Treatment of MuSK-Associated Myasthenia Gravis.
@en
Treatment of MuSK-Associated Myasthenia Gravis.
@nl
P2093
P2860
P1476
Treatment of MuSK-Associated Myasthenia Gravis.
@en
P2093
Ahmed Yassin
Duha Al-Shorafat
Kefah Al-Hayk
Khalid El-Salem
Salma Yahya
P2860
P2888
P356
10.1007/S11940-014-0283-8
P50
P577
2014-04-01T00:00:00Z